Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2023 1
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN).
Burchert A, Bug G, Fritz LV, Finke J, Stelljes M, Röllig C, Wollmer E, Wäsch R, Bornhäuser M, Berg T, Lang F, Ehninger G, Serve H, Zeiser R, Wagner EM, Kröger N, Wolschke C, Schleuning M, Götze KS, Schmid C, Crysandt M, Eßeling E, Wolf D, Wang Y, Böhm A, Thiede C, Haferlach T, Michel C, Bethge W, Wündisch T, Brandts C, Harnisch S, Wittenberg M, Hoeffkes HG, Rospleszcz S, Burchardt A, Neubauer A, Brugger M, Strauch K, Schade-Brittinger C, Metzelder SK. Burchert A, et al. Among authors: esseling e. J Clin Oncol. 2020 Sep 10;38(26):2993-3002. doi: 10.1200/JCO.19.03345. Epub 2020 Jul 16. J Clin Oncol. 2020. PMID: 32673171 Clinical Trial.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause SW, Bethge W, Jost E, Platzbecker U, Klein SA, Schubert J, Niederland J, Kaufmann M, Schäfer-Eckart K, Schaich M, Baldauf H, Stölzel F, Petzold C, Röllig C, Alakel N, Steffen B, Hauptrock B, Schliemann C, Sockel K, Lang F, Kriege O, Schaffrath J, Reicherts C, Berdel WE, Serve H, Ehninger G, Schmidt AH, Bornhäuser M, Mikesch JH, Schetelig J; Study Alliance Leukemia and the German Cooperative Transplant Study Group. Stelljes M, et al. Lancet Haematol. 2024 May;11(5):e324-e335. doi: 10.1016/S2352-3026(24)00065-6. Epub 2024 Apr 4. Lancet Haematol. 2024. PMID: 38583455 Free article. Clinical Trial.
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.
Ronnacker J, Grau M, Klasmeier M, Klesse C, Baldauf H, Abert S, Berdel AF, Füsser FT, Sandmann S, Albring J, Reicherts C, Call S, Marx J, Floeth M, Eßeling E, Kolloch L, Berning P, Scheller A, Wethmar K, Schmidt H, Schlüter B, Berdel WE, Ostendorf BN, Tavazoie SF, Mikesch JH, Lenz G, Fleischhauer K, Schetelig J, Stelljes M, Schliemann C. Ronnacker J, et al. Among authors: esseling e. Blood. 2025 Apr 24;145(17):1943-1956. doi: 10.1182/blood.2024026886. Blood. 2025. PMID: 39813679
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E, Mikesch JH, Hafner S, Simmet T, Wozniak A, Schöffski P, Larsson O, Wardelmann E, Trautmann M, Hartmann W. Isfort I, et al. Among authors: esseling e. Clin Cancer Res. 2019 Jun 15;25(12):3718-3731. doi: 10.1158/1078-0432.CCR-17-3553. Epub 2019 Feb 27. Clin Cancer Res. 2019. PMID: 30814111
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.
Berning P, Kolloch L, Reicherts C, Call S, Marx J, Floeth M, Esseling E, Ronnacker J, Albring J, Schliemann C, Lenz G, Stelljes M. Berning P, et al. Among authors: esseling e. Bone Marrow Transplant. 2024 Aug;59(8):1097-1106. doi: 10.1038/s41409-024-02295-2. Epub 2024 May 3. Bone Marrow Transplant. 2024. PMID: 38702400 Free PMC article.
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Schroeder T, Stelljes M, Christopeit M, Esseling E, Scheid C, Mikesch JH, Rautenberg C, Jäger P, Cadeddu RP, Drusenheimer N, Holtick U, Klein S, Trenschel R, Haas R, Germing U, Kröger N, Kobbe G. Schroeder T, et al. Among authors: esseling e. Haematologica. 2023 Nov 1;108(11):3001-3010. doi: 10.3324/haematol.2022.282570. Haematologica. 2023. PMID: 37259567 Free PMC article.
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.
Ronnacker J, Urbahn MA, Reicherts C, Kolloch L, Berning P, Sandmann S, Eßeling E, Call S, Floeth M, Marx J, Albring J, Mikesch JH, Schliemann C, Lenz G, Stelljes M. Ronnacker J, et al. Among authors: esseling e. Br J Haematol. 2024 Jul;205(1):280-290. doi: 10.1111/bjh.19552. Epub 2024 Jun 4. Br J Haematol. 2024. PMID: 38831752
Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma.
Eisfeld C, Eßeling E, Wullenkord R, Khandanpour C, Reusch J, Mikesch JH, Reicherts C, Kerkhoff A, Schliemann C, Kessler T, Mesters RM, Berdel WE, Lenz G, Stelljes M. Eisfeld C, et al. Among authors: esseling e. Ann Hematol. 2020 Aug;99(8):1907-1915. doi: 10.1007/s00277-020-04068-5. Epub 2020 May 22. Ann Hematol. 2020. PMID: 32444892 Free PMC article. Clinical Trial.
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning.
Kolloch L, Berning P, Albring JC, Ronnacker J, Reicherts C, Call S, Marx J, Floeth M, Esseling E, Eich HT, Schliemann C, Mikesch JH, Lenz G, Stelljes M. Kolloch L, et al. Among authors: esseling e. Bone Marrow Transplant. 2025 Aug 22. doi: 10.1038/s41409-025-02702-2. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 40847021 No abstract available.
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia.
Wethmar K, Matern S, Eßeling E, Angenendt L, Pfeifer H, Brüggemann M, Stelmach P, Call S, Albring JC, Mikesch JH, Reicherts C, Groth C, Schliemann C, Berdel WE, Lenz G, Stelljes M. Wethmar K, et al. Among authors: esseling e. Bone Marrow Transplant. 2020 Jul;55(7):1410-1420. doi: 10.1038/s41409-020-0801-0. Epub 2020 Jan 30. Bone Marrow Transplant. 2020. PMID: 32001801
11 results